HOOKIPA PHARMA INC (HOOK)

US43906K1007 - Common Stock

0.8154  +0 (+0.54%)

After market: 0.8184 +0 (+0.37%)

Fundamental Rating

4

Taking everything into account, HOOK scores 4 out of 10 in our fundamental rating. HOOK was compared to 587 industry peers in the Biotechnology industry. HOOK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HOOK is valued quite expensive, but it does show an excellent growth.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HOOK has reported negative net income.
In the past year HOOK has reported a negative cash flow from operations.
HOOK had negative earnings in each of the past 5 years.
In the past 5 years HOOK always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -32.58%, HOOK is in the better half of the industry, outperforming 68.55% of the companies in the same industry.
HOOK has a better Return On Equity (-45.47%) than 70.77% of its industry peers.
Industry RankSector Rank
ROA -32.58%
ROE -45.47%
ROIC N/A
ROA(3y)-49.57%
ROA(5y)-40.42%
ROE(3y)-79.53%
ROE(5y)-60.66%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HOOK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

HOOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
HOOK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HOOK has more shares outstanding
Compared to 1 year ago, HOOK has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -2.18, we must say that HOOK is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of HOOK (-2.18) is comparable to the rest of the industry.
HOOK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.18
ROIC/WACCN/A
WACC8.83%

2.3 Liquidity

HOOK has a Current Ratio of 4.50. This indicates that HOOK is financially healthy and has no problem in meeting its short term obligations.
HOOK's Current ratio of 4.50 is in line compared to the rest of the industry. HOOK outperforms 49.57% of its industry peers.
A Quick Ratio of 4.50 indicates that HOOK has no problem at all paying its short term obligations.
The Quick ratio of HOOK (4.50) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.5
Quick Ratio 4.5

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.65% over the past year.
The Revenue has grown by 234.93% in the past year. This is a very strong growth!
The Revenue has been growing by 21.41% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)45.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q140.74%
Revenue 1Y (TTM)234.93%
Revenue growth 3Y0.93%
Revenue growth 5Y21.41%
Revenue growth Q2Q1052.36%

3.2 Future

Based on estimates for the next years, HOOK will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.92% on average per year.
HOOK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 58.43% yearly.
EPS Next Y58.56%
EPS Next 2Y18.57%
EPS Next 3Y7.51%
EPS Next 5Y15.92%
Revenue Next Year74.88%
Revenue Next 2Y-10.91%
Revenue Next 3Y-32.32%
Revenue Next 5Y58.43%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HOOK. In the last year negative earnings were reported.
Also next year HOOK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.57%
EPS Next 3Y7.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HOOK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HOOKIPA PHARMA INC

NASDAQ:HOOK (5/17/2024, 7:04:22 PM)

After market: 0.8184 +0 (+0.37%)

0.8154

+0 (+0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap78.73M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.58%
ROE -45.47%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.5
Quick Ratio 4.5
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)45.65%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y58.56%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)234.93%
Revenue growth 3Y0.93%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y